Changes in inflammation and QoL after a single dose of infliximab during ongoing IBD treatment. [electronic resource]
Producer: 20120716Description: 486-90 p. digitalISSN:- 1536-4801
- Adolescent
- Antibodies, Monoclonal -- therapeutic use
- C-Reactive Protein -- metabolism
- Child
- Cohort Studies
- Crohn Disease -- diagnosis
- Dose-Response Relationship, Drug
- Female
- Gastrointestinal Agents -- therapeutic use
- Humans
- Inflammation -- drug therapy
- Inflammatory Bowel Diseases -- drug therapy
- Infliximab
- Male
- Quality of Life
- Surveys and Questionnaires
- Treatment Outcome
- Young Adult
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural
There are no comments on this title.
Log in to your account to post a comment.